mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |